The CFO reaffirmed the company’s firm conviction, that the fundamental long-term market outlook has not been impacted by COVID. He furthermore reaffirmed that the technology trade-up process, which is expected to be a key growth driver in the long-term, continues to be a key focus area, combined with their ongoing progress of establishing more emerging markets with direct sales forces and driving innovation for future products e.g. mind controlled prosthetics/ exoskeletons.